title: The concomitant presence of lupus anticoagulant, anticardiolipin and anti-beta2-glycoprotein i antibodies could be associated with acquired activated protein c resistance in non-systemic lupus erythematosus patients.
authors.forename: Laura
authors.initials: L
authors.lastname: Gennari
authors.forename: Alicia
authors.initials: A
authors.lastname: Blanco
authors.forename: María Fabiana
authors.initials: MF
authors.lastname: Alberto
authors.forename: Silvia
authors.initials: S
authors.lastname: Grosso
authors.forename: María Angela
authors.initials: MA
authors.lastname: Lazzari
mesh_terms: D020016:Activated Protein C Resistance / Q000276:immunology*; D017153:Antibodies, Anticardiolipin / Q000032:analysis; D016736:Antiphospholipid Syndrome / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis*; D006023:Glycoproteins / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D053482:beta 2-Glycoprotein I
chemical_list: D017153:Antibodies, Anticardiolipin; D001323:Autoantibodies; D006023:Glycoproteins; D016682:Lupus Coagulation Inhibitor; D053482:beta 2-Glycoprotein I